Difelikefalin versus Gabapentinoids for chronic kidney disease-associated pruritus in dialysis patients: A systematic review and meta-analysis with adjusted indirect comparison
Year: 2026
Type: study-registration
Abstract: This project will be a systematic review and meta-analysis comparing difelikefalin and gabapentinoids (gabapentin and pregabalin) for the treatment of chronic kidney disease-associated pruritus (uremic pruritus) in adults receiving maintenance dialysis. Because no randomized trial has directly compared these two drug classes, this review will pool placebo-controlled trials of each drug class separately, then apply an adjusted indirect comparison (Bucher method) to estimate their relative effect. The primary outcome will be change in itch intensity (Worst Itch Numeric Rating Scale). Secondary outcomes will include pruritus-related quality of life, sleep disturbance, and adverse events with particular attention to CNS-related adverse events (somnolence, dizziness, falls) given known risks of gabapentinoid accumulation in dialysis patients. This registration documents the protocol prospectively, prior to data extraction and synthesis, in line with standard systematic review reporting practices.
Source: Open Science Framework
Author: Shah Bano
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7208831930
